Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$16,429,072
+$1,970,337 QoQ
Shares Held
65,288
-1.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#698
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rathbones Group PLC holds $2,298,575,113 across 12 Drug Manufacturers - General names. ABBV ranks #5 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
7,979,150 | $1,513,006,423 | |
| 2 | LLY |
ELI LILLY & Co
|
447,654 | $536,929,681 | |
| 3 | JNJ |
Johnson & Johnson
|
691,961 | $175,737,335 | |
| 4 | MRK |
Merck & Co., Inc.
|
207,542 | $26,669,147 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
65,288 | $16,429,072 | |
| 6 | PFE |
Pfizer Inc
|
433,531 | $10,439,426 | |
| 7 | AMGN |
Amgen Inc
|
20,628 | $7,469,811 | |
| 8 | NVS |
Novartis AG
|
43,692 | $6,847,410 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,429,072 | 65,288 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $14,458,735 | 66,480 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $15,273,185 | 66,844 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $16,586,367 | 71,635 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $13,311,367 | 71,713 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $15,474,309 | 73,856 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $14,114,355 | 79,428 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $17,724,817 | 89,755 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $16,171,591 | 94,284 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $17,904,618 | 98,323 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $16,470,831 | 106,284 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $16,278,246 | 109,206 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $12,519,919 | 92,926 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $15,083,733 | 94,646 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $15,967,068 | 98,800 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $13,506,089 | 100,634 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,410,499 | 100,617 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $16,401,317 | 101,174 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $13,771,398 | 101,709 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $10,907,275 | 101,115 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $11,941,304 | 106,013 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $11,341,888 | 104,804 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $11,106,954 | 103,658 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $9,489,675 | 108,342 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $10,736,572 | 109,356 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $8,506,537 | 111,649 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||